The global intragastric balloons market size reached USD 70.2 Million in 2024. Looking forward, IMARC Group expects the market to reach USD 169.6 Million by 2033, exhibiting a growth rate (CAGR) of 9.
Last updated
Market Overview:
The intragastric balloons market is experiencing rapid growth, driven by technological advancements, evolving consumer expectations, and regulatory changes. According to IMARC Group's latest research publication, "Intragastric Balloons Market Report by Product (Single Intragastric Balloon, Double Intragastric Balloon, Triple Intragastric Balloon), Filling Material (Saline Filling, Gas Filling), Implanting Procedure (Surgical, Non-Surgical), Application (Obesity, Diabetes, Diet Control, Weight-Loss, Pre-Operative Weight Reduction, and Others), End-User (Hospitals and Clinics, Ambulatory Surgical Centers, and Others), and Region 2025-2033", The global size reached USD 70.2 Million in 2024. Looking forward, IMARC Group expects the market to reach USD 169.6 Million by 2033, exhibiting a growth rate (CAGR) of 9.79% during 2025-2033.
This detailed analysis primarily encompasses industry size, business trends, market share, key growth factors, and regional forecasts. The report offers a comprehensive overview and integrates research findings, market assessments, and data from different sources. It also includes pivotal market dynamics like drivers and challenges, while also highlighting growth opportunities, financial insights, technological improvements, emerging trends, and innovations. Besides this, the report provides regional market evaluation, along with a competitive landscape analysis.
Our report includes:
Market Dynamics
Market Trends And Market Outlook
Competitive Analysis
Industry Segmentation
Strategic Recommendations
Factors Affecting the Growth of the Intragastric Balloons Industry:
Obesity Epidemic Fuels Demand:
Obesity rates are rising globally, driving growth in the intragastric balloon market. Over 650 million adults are classified as obese worldwide. This surge has increased demand for minimally invasive weight-loss solutions. Intragastric balloons are a popular non-surgical option compared to bariatric surgery. They offer shorter recovery times and lower risks. Patients and healthcare providers both seek treatments for long-term weight management. This helps increase adoption. Emerging markets in Asia-Pacific and Latin America have great growth potential. Awareness of these devices is increasing.
Technological Innovations Drive Adoption:
Advancements in intragastric balloon design are changing market dynamics. New devices offer better durability, adjustable volumes, and improved patient comfort. These changes address past concerns about complications and ease of use. Innovations like swallowable balloons remove the need for endoscopy. Integrated health-tracking sensors attract tech-savvy consumers. Manufacturers are also investing in AI-driven patient monitoring systems. This helps optimize outcomes and builds trust in the treatment. These changes make the product more appealing. They also market intragastric balloons as a budget-friendly option in the weight-loss industry.
Insurance Coverage Expands Access:
Expanding insurance reimbursement for intragastric procedures is accelerating market accessibility. Historically, high out-of-pocket costs limited adoption, but insurers in North America and Europe are increasingly covering the treatment for eligible patients. Regulatory approvals, such as the FDA’s expanded indications for certain balloons, have bolstered payer confidence in their efficacy. This shift is reducing financial barriers, particularly for middle-income demographics, while encouraging clinics to offer the procedure. As coverage extends to emerging economies, affordability improvements are expected to drive sustained demand, positioning reimbursement policies as a key growth catalyst.
Leading Companies Operating in the Global Intragastric Balloons Industry:
being Apollo Endosurgery
Obalon Therapeutics Inc.
ReShape Medical Inc.
Medicone
Medsil
Allurion Technologies Inc.
Helioscopie
Spatz Fgia Inc.
PlenSat
Districlass Medical SA
Endalis
Lexel SRL
Silimed Inc.
Shandong Institute of Medical Instruments
Insurtech Market Report Segmentation:
Breakup by Product:
Single Intragastric Balloon
Double Intragastric Balloon
Triple Intragastric Balloon
Breakup by Implanting Procedure:
Surgical
Non-Surgical
Breakup by Application:
Obesity
Diabetes
Diet Control
Weight-Loss
Pre-Operative Weight Reduction
Others
Breakup by End-User:
Hospitals and Clinics
Ambulatory Surgical Centers
Others
Regional Insights:
North America (United States, Canada)
Asia Pacific (China, Japan, India, South Korea, Australia, Indonesia, Others)
Europe (Germany, France, United Kingdom, Italy, Spain, Russia, Others)
Latin America (Brazil, Mexico, Others)
Middle East and Africa
Research Methodology:
The report employs a comprehensive research methodology, combining primary and secondary data sources to validate findings. It includes market assessments, surveys, expert opinions, and data triangulation techniques to ensure accuracy and reliability.
Note: If you require specific details, data, or insights that are not currently included in the scope of this report, we are happy to accommodate your request. As part of our customization service, we will gather and provide the additional information you need, tailored to your specific requirements. Please let us know your exact needs, and we will ensure the report is updated accordingly to meet your expectations.
About Us:
IMARC Group is a global management consulting firm that helps the world’s most ambitious changemakers to create a lasting impact. The company provide a comprehensive suite of market entry and expansion services. IMARC offerings include thorough market assessment, feasibility studies, company incorporation assistance, factory setup support, regulatory approvals and licensing navigation, branding, marketing and sales strategies, competitive landscape and benchmarking analyses, pricing and cost research, and procurement research.
Contact Us:
IMARC Group
134 N 4th St. Brooklyn, NY 11249, USA
Email: sales@imarcgroup.com
Tel No:(D) +91 120 433 0800
United States: +1-631-791-1145
Grab a sample PDF of this report:
